An iron loaded liver from a 40 year old man with occult haemochromatosis was transplanted into a 19 year old woman with acute liver failure secondary to a paracetamol overdose. Increased parenchymal hepatic iron was found in a liver specimen at biopsy undertaken because of mild rejection 30 days after transplantation. After transplantation the patient had two episodes of liver rejection confirmed by biopsy. The hepatic iron concentration fell from 161 ,mol/g on day 30 after transplant to 26.5 imol/g (normal <40) on day 210. Iron absorption, measured 45 days after transplant, was in the normal range at 12-4%. The rapid fall in hepatic iron and the normal iron absorption study result suggest that the genetic defect of haemochromatosis is not exclusively an intrahepatic defect.
Haemochromatosis is a genetic disease of unknown cause that affects approximately one in 400 of the white population.' The disease is characterised by increased intestinal absorption of iron that eventually leads to parenchymal iron deposition in the liver, pancreas, and heart. Organ damage and clinical symptoms do not usually appear until the fifth decade in men and the sixth decade in women. 2 Theories on the pathogenesis of haemochromatosis have postulated that the primary metabolic defect is in the intestinal mucosa,15 the reticuloendothelial system,6 or the liver.78 In this report, we describe the indirect evidence against an intrahepatic defect as the primary defect in haemochromato- The pathogenesis of haemochromatosis remains unknown. Patients with this disorder have increased intestinal absorption of iron which accumulates in the liver, pancreas, and heart causing parenchymal damage over many years. The factors that control iron absorption are poorly understood even in the normal human. A defect in the intestinal regulation of iron absorption has been postulated as the primary defect in haemochromatosis," but iron absorption does respond to body iron stores by decreasing as these increase.13 A generalised defect in the reticuloendothelial system has also been proposed, with the rapid release of iron by macrophages.6 Since haemochromatosis has major clinical sequelae in the liver, an intrahepatic lesion is another possibility.78 Increased hepatic iron uptake has been found in patients with haemochromatosis by scanning the liver after the infusion of radiolabelled transferrin. 8 Orthotopic liver transplantation in human beings has provided the opportunity to study the effects of liver replacement on many inherited metabolic diseases. If the metabolic defect of haemochromatosis had been transplanted into this patient, hepatic iron would continue to accumulate as a result of the increased intestinal iron absorption associated with the disease. The rapid reduction of hepatic iron after liver transplantation with normal iron absorption in this patient suggests that the primary metabolic defect of haemochromatosis does not reside exclusively in the liver. However, inflammation in the liver associated with rejection would result in the release ofiron into the circulation, redistribution of iron from the parenchyma to macrophages and may contribute to the increased serum ferritin value. Furthermore, the effects of liver transplantation on iron absorption and mobilisation of iron are not clearly understood. Experimental liver transplantation of iron loaded livers in rats has shown some reduction in hepatic iron with rejection but not to the degree seen in this patient.7 Experimental iron loading of animals has been shown to cause lipid peroxidation with the production of free radicals that can cause tissue damage. 14 It is possible that in this patient hepatic rejection led to the release of free iron which further exacerbated the hepatic inflammation. The definitive proof that this patient will not develop progressive iron overload will require long term follow up with assessment of body iron stores by hepatic iron and serum ferritin determination. 
